Previous Close | 9.35 |
Open | 10.51 |
Bid | 12.15 |
Ask | 12.40 |
Strike | 200.00 |
Expire Date | 2025-01-17 |
Day's Range | 10.46 - 12.25 |
Contract Range | N/A |
Volume | |
Open Interest | 2.73k |
An FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to target the WHO-recommended JN.1 variant or the KP.2 variant which is the currently dominating strain in the country.
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Moderna, Inc. (NASDAQ:MRNA) is the top gene therapy stock to invest in now. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]